Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan
Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan is a paper indexed in PICO Portal from OpenAlex.
How many citations does Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan have?
Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan has 4 citations in the OpenAlex counts PICO Portal stores.
When was Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan published?
Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan has 2021 year in the PICO Portal index.
What is the open-access status of Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan?
Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan has gold oa status in the PICO Portal index.
What is the DOI of Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan?
The DOI for Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan is on the source record.
What is the OpenAlex record for Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan?
The OpenAlex for Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan is on the source record.